Central nervous system cystic malformation

Central nervous system cystic malformation (Orphanet code 269194) is a broad grouping term used in rare disease classification to encompass a heterogeneous set of congenital malformations characterized by the presence of cystic structures within the central nervous system (brain and/or spinal cord). These malformations arise during embryonic development and can include entities such as arachnoid cysts, porencephalic cysts, Dandy-Walker malformation, Blake's pouch cyst, and other developmental cystic anomalies of the brain. The underlying causes are diverse and may involve genetic mutations, chromosomal abnormalities, or disruptions during fetal brain development. Clinical presentation varies widely depending on the size, location, and type of cystic malformation. Symptoms may include hydrocephalus (abnormal accumulation of cerebrospinal fluid), macrocephaly, developmental delay, seizures, motor impairment, and in some cases intellectual disability. Some cystic malformations may remain asymptomatic and be discovered incidentally on neuroimaging. Neurological deficits can range from mild to severe depending on the degree of brain tissue involvement and whether there is associated obstruction of cerebrospinal fluid pathways. Because this is a classification grouping rather than a single disease entity, there is no single treatment approach. Management is tailored to the specific type of cystic malformation and its clinical consequences. Neurosurgical intervention, including cyst fenestration or shunt placement, may be required for symptomatic cases with hydrocephalus or mass effect. Supportive therapies such as physical therapy, occupational therapy, speech therapy, and seizure management with antiepileptic medications are commonly employed. Genetic counseling may be recommended when a hereditary cause is identified.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Central nervous system cystic malformation